Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Australian researchers develop hydrogel to combat Parkinson's
Australian researchers develop hydrogel to combat Parkinson's
SYDNEY, Aug 10 (Reuters) - Australian researchers have created a hydrogel that could be used as a one-off intervention to treat Parkinson's disease and possibly other neurological conditio...
Bavarian Nordic Reports Initial Results from First-in-Human Trial of COVID-19 Vaccine
Bavarian Nordic Reports Initial Results from First-in-Human Trial of COVID-19 Vaccine
COPENHAGEN, Denmark, August 9, 2021 – Bavarian Nordic A/S (OMX.
University of Glasgow Researchers Propose A Smartphone-Based DNA Diagnostics For Malaria Detection Using deep Learning
University of Glasgow Researchers Propose A Smartphone-Based DNA Diagnostics For Malaria Detection Using deep Learning
Malaria is one of the world’s leading reasons for illness and death.
FDA COVID-19 Vaccine Approval: Live Updates on Pfizer, Moderna, and J&J Vaccines
FDA COVID-19 Vaccine Approval: Live Updates on Pfizer, Moderna, and J&J Vaccines
An emergency use authorization (EUA) allows for vaccines, tests, and treatments to be used during a public health emergency based on best available evidence — without being fully FDA-approve...
AZ’s Forxiga gains EC, MHRA approvals for chronic kidney disease
AZ’s Forxiga gains EC, MHRA approvals for chronic kidney disease
AstraZeneca’s Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved by the European Commission for the treatment of chronic kidney disease &#...
Gilead to require U.S. workers receive COVID-19 vaccine
Gilead to require U.S. workers receive COVID-19 vaccine
Aug 9 (Reuters) - Gilead Sciences Inc (GILD.
U.S. FDA approves another Sanofi drug for rare muscle disorder Pompe disease
U.S. FDA approves another Sanofi drug for rare muscle disorder Pompe disease
Aug 6 (Reuters) - Sanofi's (SASY.
Eisai and Biogen Gun for Speedy Approval for Another Alzheimer's Drug
Eisai and Biogen Gun for Speedy Approval for Another Alzheimer's Drug
Massachusetts-based biotechnology firm Biogen and its Tokyo-based partner Eisai are seeking a speedy approval from the U.
First-Ever Single-Dose Chikungunya Vaccine Touts Positive Phase III Results
First-Ever Single-Dose Chikungunya Vaccine Touts Positive Phase III Results
French specialty vaccine maker Valneva has shared positive topline results from ongoing trials for a potential single-shot vaccine against chikungunya.
Spectrum Pharmaceuticals Receives Complete Response Letter from FDA for ROLONTIS® (eflapegrastim)
Spectrum Pharmaceuticals Receives Complete Response Letter from FDA for ROLONTIS® (eflapegrastim)
HENDERSON, Nev.
Bayer Strengthens Drug Discovery Platform Through Acquisition of Vividion Therapeutics
Bayer Strengthens Drug Discovery Platform Through Acquisition of Vividion Therapeutics
BERLIN--(BUSINESS WIRE)--Bayer AG today announced the acquisition of Vividion Therapeutics, Inc.
Bayer Drops $2 Billion to Drug the Undruggable
Bayer Drops $2 Billion to Drug the Undruggable
Bayer AG is buying Vividion Therapeutics, a San Diego-based company that focuses on drug development using protein surface screening, in a $2 billion deal.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand